Diabetes
Select from the various topics below and click on the link to get an inside view of how our P&T committee responded to the issue.
Cost Comparison: Actos vs. Avandia and Metformin vs. Glumetza
Advantages and Disadvantages of DPP-IV Inhibitors
Pricing comparison: Apidra vs. Novolog
Apidra: Lack of Differentiation
Clinical Comparison: Byetta vs Januvia
Consideration of Marketing Efforts On Forumlary
Side effect profiles: Januvia vs. Galvus
Levemir: Clinical Disadvantages
DPP-IVs: Elderly Use and Alternatives to Metformin
Contracting strategy: Eli Lilly vs. Novo Nordisk
Exubera Discussion of Issues With Delivery Device
Glumetza GI Tolerability Side Effect Profile
Januvia and Use In Primary Care
Clinical dosing comparison: Januvia vs. Galvus
Januvia's Place in Therapy vs. Actos and Avandia
Price discussion1: Lantus vs. Levemir
Switch discussion: Levemir vs. Lantus
Lilly Marketshare: Novolog vs. Humalog
Safety Discussion: New Diabetes agents
Victoza Formulary Recommendation
* PTP video clips play in windows media
player. To download
click here,
Mac users
click here.